基于SFIC模型的我国医联体协同路径研究  

Research on Collaborative Path of Medical Alliance in China Based on SFIC Model

作　　者：杨宇莎 陈永法[1] YANG Yu-sha;CHEN Yong-fa(不详;School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing Jiangsu 211198,China)

机构地区：[1]中国药科大学国际医药商学院,江苏南京211198

出　　处：《卫生经济研究》2022年第5期52-55,共4页

基　　金：国家社会科学基金(15BZZ052)。

摘　　要：基于SFIC模型,围绕起始条件、催化领导、制度设计、协同过程四个维度,全面剖析我国医联体协同困境,进而提出协同路径:以公益价值为导向,强化协同起始条件;激发和培育多元主体,发挥催化领导力;构建系统完备的政策体系,完善制度设计;运用多样化手段,优化协同过程。Aiming at the problem that the synergy of the medical alliance in China is not significant at present,based on the SFIC model,this paper comprehensively analyzed the collaborative dilemma around the four dimensions of starting conditions,facilitative leadership,institutional design and collaborative process,and then put forward the collaborative path of the medical alliance:strengthening the collaborative starting conditions guided by public welfare value,stimulating and cultivating multiple subjects and giving full play to facilitative leadership,building a systematic policy system to improve the system design,using diversified means to optimize the collaborative process.

关 键 词：医联体 SFIC模型 协同路径 

分 类 号：R19[医药卫生—卫生事业管理]